|
|
||||||||
-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line
Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, Texas
Submitted 2 August 2004 ; accepted in final form 5 October 2004
The role of membrane estrogen receptor-
(mER
) in rapid nongenomic responses to 17
-estradiol (E2) was tested in sublines of GH3/B6 rat prolactinoma cells selected for high (GH3/B6/F10) and low (GH3/B6/D9) mER
expression. E2 elicited rapid, concentration-dependent intracellular Ca2+ concentration ([Ca2+]i) increases in the F10 subline. Lack of inhibition by thapsigargin depletion of intracellular Ca2+ pools, together with abrogation of the response in Ca2+-free medium, suggested an extracellular source of Ca2+ for this response. The participation of voltage-dependant channels in the E2-induced [Ca2+]i increase was confirmed by the specific L-type Ca2+ channel inhibitor nifedipine. For comparison, the D9 mER
-depleted subline was insensitive to steroid action via this signaling mechanism. [Ca2+]i elevation was correlated with prolactin (PRL) release in the F10 cell line in as little as 3 min. E2 caused a much higher PRL release than KCl treatment (which caused maximal Ca2+ elevation), suggesting that secretion was also controlled by additional mechanisms. Participation of mER
in these effects was confirmed by the ability of E2-peroxidase (a cell-impermeable analog of E2) to cause these responses, blockage of the responses with the ER antagonist ICI 182 780, and the inability of the E2 stereoisomer 17
-E2 to elicit a response. Thus rapid exocytosis of PRL is regulated in these cells by mER
signaling to specific Ca2+ channels utilizing extracellular Ca2+ sources and additional signaling mechanisms.
prolactinoma cell line; intracellular Ca2+; L-type channel; exocytosis
This article has been cited by other articles:
![]() |
S. Zarate, G. Jaita, V. Zaldivar, D. B. Radl, G. Eijo, J. Ferraris, D. Pisera, and A. Seilicovich Estrogens exert a rapid apoptotic action in anterior pituitary cells Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E664 - E671. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Watson, Y.-J. Jeng, and M. Y. Kochukov Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation FASEB J, September 1, 2008; 22(9): 3328 - 3336. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Klinge, N. S. Wickramasinghe, M. M. Ivanova, and S. M. Dougherty Resveratrol stimulates nitric oxide production by increasing estrogen receptor {alpha}-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells FASEB J, July 1, 2008; 22(7): 2185 - 2197. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fotovati, T. Fujii, M. Yamaguchi, M. Kage, K. Shirouzu, S. Oie, Y. Basaki, M. Ono, H. Yamana, and M. Kuwano 17{beta}-Estradiol Induces Down-Regulation of Cap43/NDRG1/Drg-1, a Putative Differentiation-Related and Metastasis Suppressor Gene, in Human Breast Cancer Cells. Clin. Cancer Res., May 15, 2006; 12(10): 3010 - 3018. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Aguilar, C Bellido, J C Garrido-Gracia, R Alonso, and J E Sanchez-Criado Estradiol and its membrane-impermeable conjugate estradiol-BSA inhibit tamoxifen-stimulated prolactin secretion in incubated rat pituitaries. Reproduction, April 1, 2006; 131(4): 763 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kanda and S. Watanabe 17{beta}-Estradiol enhances heparin-binding epidermal growth factor-like growth factor production in human keratinocytes Am J Physiol Cell Physiol, April 1, 2005; 288(4): C813 - C823. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |